OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001520592

Lotus Bio-Technology Development Corp.

Lotus Bio-Technology Development Corp. (CIK 0001520592) reported net income of -$781,105 for FY2017 (2015-04-01 to 2016-03-31) and total assets of $5,463 for FY2017 (as of 2016-03-31), as filed in its 10-K filed 2016-09-27 (accession 0001511164-16-001039).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends March 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001520592
EINnot in EDGAR (or not a valid EIN)
SIC industry code0700 Agricultural Services
State or country of incorporationWY
Fiscal year endMarch 31
Filer categorySmaller reporting company
Entity typeoperating
Olympus entity IDorg_5n4zas9ed0rtbmxmjmj9ftnh07
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Net income-$781,105FY20172015-04-01 to 2016-03-3110-K2016-09-270001511164-16-001039NetIncomeLoss
Total assets$5,463FY2017as of 2016-03-3110-K2016-09-270001511164-16-001039Assets
Total liabilities$66,771FY2017as of 2016-03-3110-K2016-09-270001511164-16-001039Liabilities
Stockholders' equity-$61,308FY2017as of 2016-03-3110-K2016-09-270001511164-16-001039StockholdersEquity
Operating cash flow-$1,500FY20152014-04-01 to 2015-03-3110-K2016-09-270001511164-16-001039NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share$0 per shareFY20172015-04-01 to 2016-03-3110-K2016-09-270001511164-16-001039EarningsPerShareBasicAndDiluted
Shares outstanding82,775,000 sharesFY2017as of 2016-06-3010-K2016-09-270001511164-16-001039EntityCommonStockSharesOutstanding
  • Operating cash flow for FY2015 was restated: first reported as -$15,706 (accession 0001511164-15-000370, filed 2015-07-29).
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2008-2017, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
Net incomeFY20172015-04-01 to 2016-03-31-$781,10510-K2016-09-270001511164-16-001039
Net incomeFY20152014-04-01 to 2015-03-31-$18,72410-K2016-09-270001511164-16-001039
Net incomeFY20142013-04-01 to 2014-03-31-$18,72410-K2016-09-270001511164-16-001039
Net incomeFY20122012-04-01 to 2013-03-31-$62,13810-K2014-07-150001511164-14-000392
Net incomeFY20112011-04-01 to 2012-03-31-$35,88910-K2013-07-010001002014-13-000281
  • Net income for FY2014 was restated: first reported as -$41,643 (accession 0001511164-14-000392, filed 2014-07-15).
  • Net income for FY2011 was restated: first reported as -$51,439 (accession 0001002014-12-000328, filed 2012-06-22).

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q/A2021-04-072017-12-310001213900-21-020688f10q1217a1_lotusbio.htm
10-Q/A2021-02-232017-09-300001213900-21-011136f10q0917a2_lotusbiotech.htm
10-Q/A2021-01-272017-06-300001213900-21-004504f10q0617a2_lotusbiotech.htm
10-K/A2021-01-212017-03-310001213900-21-003397f10k2017a1_lotusbio.htm
10-Q2018-02-132017-12-310001511164-18-000078f10-q.htm
10-Q2017-11-132017-09-300001511164-17-000663f10q.htm
10-Q/A2017-09-132017-06-300001511164-17-000557f10q.htm
10-Q2017-08-212017-06-300001511164-17-000537f10q.htm
10-K2017-07-142017-03-310001511164-17-000395f10k3312017.htm
10-Q2017-05-082016-12-310001511164-17-000251f10q.htm
10-Q2016-11-212016-09-300001511164-16-001171f20161121_lotus10qsep2016bil.htm
10-Q2016-09-272016-06-300001511164-16-001040f10q6302016.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001520592published by the sourcedata.sec.gov/submissions/CIK0001520592.json2026-10-21

Former names

NameFromTo
Lotus Biotech Development Corp.2016-04-082021-04-07
Starflick.com2011-06-102016-04-05

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001520592.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001520592.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001520592" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001520592/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001520592/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1520592"}

On SEC EDGAR

About this data